Otsuka Completes Acquisition of Transcend Therapeutics to Advance Development of Innovative PTSD Treatment Otsuka America, Inc., a subsidiary of the global healthcare company Otsuka Pharmaceutical Co., Ltd., has completed its…
Gilead Sciences Donates More Than 2,000 Vials of Remdesivir to Support Uganda’s Ebola Bundibugyo Outbreak Response Gilead Sciences has announced the donation of more than 2,000 vials of its intravenous…
BeOne Medicines Showcases Promising Hematology Pipeline Data at EHA 2026, Highlighting Advances in BTK Degradation and Time-Limited Therapies BeOne Medicines Ltd., a global oncology company focused on developing innovative treatments…
Cepheid Donates Hemorrhagic Fever Tests to Support Ebola Outbreak Response in Democratic Republic of the Congo and Uganda Cepheid, a molecular diagnostics company and part of Danaher Corporation, has announced…
Next Health Announces Inaugural Longevity Summit in Nashville, Bringing Leading Experts Together to Explore the Future of Health and Wellness Next Health, a global company focused on health optimization, preventive…
Xeris Receives USPTO Notice of Allowance for New Patent Covering KEVEYIS®, Extending Potential Protection Through 2039 Xeris Pharmaceuticals, Inc., a wholly owned subsidiary of Biopharma Holdings, Inc., has announced a…
Zetagen Therapeutics Reports Promising Phase 2a Results for Investigational ZetaMet™ in Metastatic Breast Cancer Patients With Lytic Bone Lesions Zetagen Therapeutics, a clinical-stage biopharmaceutical company focused on developing innovative therapies…
Paragon Biosciences Completes Sale of Emalex Biosciences to Teva, Marking Another Milestone in CNS Drug Innovation Paragon Biosciences has announced the successful completion of the sale of Emalex Biosciences to…
BeOne Medicines Highlights Long-Term BRUKINSA Benefits in Older CLL Patients at EHA 2026 BeOne Medicines Ltd., a global oncology company dedicated to advancing innovative cancer therapies, has announced the presentation…
LivaNova Strengthens Board Leadership with Appointment of Jette Nygaard-Andersen LivaNova PLC, a global medical technology company focused on developing innovative therapies for patients with neurological and cardiovascular conditions, has announced…
Merck Animal Health to Acquire TARGAN, Expanding Poultry Technology and Biodevice Innovation Capabilities Merck Animal Health, known as MSD Animal Health outside the United States and Canada and operating as…
Anocca Doses First Patients in VIDAR-1 Trial of ANOC-001 TCR-T Therapy for KRAS-Mutated Pancreatic Cancer Anocca AB, a clinical-stage biotechnology company focused on the development of advanced T-cell immunotherapies, has…